{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:07:52Z","timestamp":1784099272019,"version":"3.55.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13212","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:25:17Z","timestamp":1781612717000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Cold agglutination as a pivotal diagnostic clue for Waldenstr\u00f6m macroglobulinemia: A rare case report with diagnostic and therapeutic insights"],"prefix":"10.3892","volume":"32","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The People's Hospital of Longhua, Shenzhen, Guangdong 518109, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwu","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The People's Hospital of Longhua, Shenzhen, Guangdong 518109, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shenzhen People's Hospital, Shenzhen, Guangdong 518020, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The People's Hospital of Longhua, Shenzhen, Guangdong 518109, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The People's Hospital of Longhua, Shenzhen, Guangdong 518109, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518055, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghong","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The People's Hospital of Longhua, Shenzhen, Guangdong 518109, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"key20260715092743_b1-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/ajh.27666","article-title":"Waldenstr\u00f6m macroglobulinemia: 2025 update on diagnosis, risk stratification, and management","volume":"100","author":"Gertz","year":"2025","journal-title":"Am J Hematol"},{"key":"key20260715092743_b2-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"e70071","key":"key20260715092743_b3-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70071","article-title":"Diagnosis and management of Waldenstrom's macroglobulinemia","volume":"43 (Suppl 2)","author":"Treon","year":"2025","journal-title":"Hematol Oncol"},{"key":"key20260715092743_b4-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.seminhematol.2023.03.008","article-title":"The epidemiology of Waldenstr\u00f6m macroglobulinemia","volume":"60","author":"McMaster","year":"2023","journal-title":"Semin Hematol"},{"issue":"1708","key":"key20260715092743_b5-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15131708","article-title":". Challenges, difficulties, and delayed diagnosis of multiple myeloma","volume":"15","author":"Zorlu","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"2654","key":"key20260715092743_b6-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15202654","article-title":"A rare combination: Cold agglutinin disease followed by Waldenstr\u00f6m macroglobulinemia-A case of early treatment response","volume":"15","author":"Kozub","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"key20260715092743_b7-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1182\/hematology.2025000718","article-title":"Diagnosis and management of cold agglutinin disease","volume":"2025","author":"Berentsen","year":"2025","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"433","key":"key20260715092743_b8-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.15179","article-title":"Morphological, immunophenotypic and neuroradiological characteristics of primitive B-large cell diffuse lymphoma of the central nervous system: A retrospective cohort analysis","volume":"30","author":"Scarcella","year":"2025","journal-title":"Oncol Lett"},{"key":"key20260715092743_b9-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"381","DOI":"10.6004\/jadpro.2020.11.4.5","article-title":"Waldenstr\u00f6m macroglobulinemia: Clinical presentation, diagnosis, and management","volume":"11","author":"Hobbs","year":"2020","journal-title":"J Adv Pract Oncol"},{"key":"key20260715092743_b10-ETM-32-2-13212","author":"Puig"},{"issue":"e70525","key":"key20260715092743_b11-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70525","article-title":"Mutational landscape of bone marrow CD19 and CD138 cells in Waldenstr\u00f6m macroglobulinemia (WM) and IgM monoclonal gammopathy of undetermined significance (IgM MGUS)","volume":"13","author":"Trojani","year":"2024","journal-title":"Cancer Med"},{"issue":"e240001","key":"key20260715092743_b12-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0001","article-title":"Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Kumar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20260715092743_b13-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s00277-024-05807-8","article-title":"Flow-cytometry assessment of DNA content and immunophenotyping of immune-cells in lymph-node-specimens as a potential diagnostic signature of aggressiveness in B-non-hodgkin lymphomas","volume":"103","author":"Azoulay","year":"2024","journal-title":"Ann Hematol"},{"key":"key20260715092743_b14-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Avet-Loiseau","year":"2003","journal-title":"Blood"},{"key":"key20260715092743_b15-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"key20260715092743_b16-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"key20260715092743_b17-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","article-title":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia","volume":"137","author":"Naderi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"key20260715092743_b18-ETM-32-2-13212","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/hemato3040040","article-title":"Cold agglutinin disease: Improved understanding of pathogenesis helps define targets for therapy","volume":"3","author":"Berentsen","year":"2022","journal-title":"Hemato"},{"issue":"590","key":"key20260715092743_b19-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00590","article-title":"New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia","volume":"11","author":"Berentsen","year":"2020","journal-title":"Front Immunol"},{"key":"key20260715092743_b20-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Blood"},{"key":"key20260715092743_b21-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/JBM.S177621","article-title":"Cold agglutinin disease: Current challenges and future prospects","volume":"10","author":"Berentsen","year":"2019","journal-title":"J Blood Med"},{"issue":"1688","key":"key20260715092743_b22-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061688","article-title":"Immunoglobulin M paraproteinaemias","volume":"12","author":"Girard","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16988","key":"key20260715092743_b23-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44210-7","article-title":"Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network","volume":"13","author":"Yadav","year":"2023","journal-title":"Sci Rep"},{"key":"key20260715092743_b24-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00277-023-05345-9","article-title":"Waldenstr\u00f6m macroglobulinemia: A review of pathogenesis, current treatment, and future prospects","volume":"103","author":"Ghafoor","year":"2024","journal-title":"Ann Hematol"},{"key":"key20260715092743_b25-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2257.2003.00511.x","article-title":"IgM myeloma and Waldenstrom's macroglobulinemia: A distinct clinical feature, histology, immunophenotype, and chromosomal abnormality","volume":"25","author":"Chehal","year":"2003","journal-title":"Clin Lab Haematol"},{"key":"key20260715092743_b26-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"issue":"e70620","key":"key20260715092743_b27-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70620","article-title":"Phenotypic profile of Waldenstr\u00f6m macroglobulinaemia B-cells: Establishment of a diagnosis scoring system and clinico-biological correlations","volume":"29","author":"Sourdeau","year":"2025","journal-title":"J Cell Mol Med"},{"issue":"1370854","key":"key20260715092743_b28-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1370854","article-title":"Targeted therapy for multiple myeloma: An overview on CD138-based strategies","volume":"14","author":"Riccardi","year":"2024","journal-title":"Front Oncol"},{"issue":"e27","key":"key20260715092743_b29-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.27","article-title":"Single-cell analysis of MYD88L265P and MYD88WT Waldenstr\u00f6m macroglobulinemia patients","volume":"8","author":"Bagratuni","year":"2024","journal-title":"Hemasphere"},{"key":"key20260715092743_b30-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-18-0215","article-title":"MYD88 L265P mutation in lymphoid malignancies","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res"},{"issue":"5507","key":"key20260715092743_b31-ETM-32-2-13212","article-title":"Clinical and prognostic impact of (11;14)(Q13;Q32) translocation on patients with multiple myeloma","volume":"134","author":"Miura","year":"2019","journal-title":"Blood"},{"key":"key20260715092743_b32-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.2169\/internalmedicine.4774-24","article-title":"Successful salvage therapy with pomalidomide, cyclophosphamide, and dexamethasone for IgM myeloma with t (11;14) and Dim CD38 expression refractory to daratumumab, lenalidomide, and dexamethasone","volume":"64","author":"Fujishima","year":"2025","journal-title":"Intern Med"},{"issue":"102715","key":"key20260715092743_b33-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102715","article-title":"How to manage waldenstr\u00f6m's macroglobulinemia in 2024","volume":"125","author":"Grunenberg","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"815","key":"key20260715092743_b34-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00815","article-title":"Hyperviscosity syndrome in paraprotein secreting conditions including waldenstrom macroglobulinemia","volume":"10","author":"Weaver","year":"2020","journal-title":"Front Oncol"},{"issue":"87","key":"key20260715092743_b35-ETM-32-2-13212","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-03970-2","article-title":"Indications and complications associated with centrifuge-based therapeutic plasma exchange-a retrospective review","volume":"26","author":"Warner","year":"2025","journal-title":"BMC Nephrol"},{"key":"key20260715092743_b36-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1200\/JCO.2008.20.4677","article-title":"Primary therapy of Waldenstr\u00f6m macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180","volume":"27","author":"Treon","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20260715092743_b37-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00277-022-05019-y","article-title":"Bortezomib-based chemotherapy for patients with Waldenstr\u00f6m macroglobulinemia: A single-center experience","volume":"102","author":"Liu","year":"2023","journal-title":"Ann Hematol"},{"key":"key20260715092743_b38-ETM-32-2-13212","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1080\/10428194.2017.1307357","article-title":"A phase II Bayesian sequential clinical trial in advanced Waldenstr\u00f6m macroglobulinemia patients treated with bortezomib: Interest of addition of dexamethasone","volume":"58","author":"Leblond","year":"2017","journal-title":"Leuk Lymphoma"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:27:49Z","timestamp":1784096869000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13212","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}